158 related articles for article (PubMed ID: 21092624)
1. [A survey of Japanese encephalitis antibody migrant workers in Shenzhen 2009].
Shan FX; Cheng JQ; Mou J; Zhang SY; He YQ; Xiao JH; Chen YJ; Huang WG; Xiong LE
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Sep; 44(9):806-9. PubMed ID: 21092624
[TBL] [Abstract][Full Text] [Related]
2. [Epidemic characteristics and viral antibody level among healthy people of Japanese B encephalitis in Henan province in 2010].
Tang XY; Kang K; Shang SY; Xu C; Li XL; Ma HX; Chen HM; Xu BL
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Oct; 46(10):888-91. PubMed ID: 23363861
[TBL] [Abstract][Full Text] [Related]
3. [Surveillance of healthy people's Japanese encephalitis neutralizing antibody in some areas of Henan Province].
Tang XY; Ma HX; Xu C; Shang SY; Kang K; Huang XY; Yin ZD; Wang HY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):401-4. PubMed ID: 22734219
[TBL] [Abstract][Full Text] [Related]
4. [The prevalence characteristic and prevention strategy of Japanese B Encephalitis in Henan province].
Tang XY; Zhang YP; Xu BL; Li XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Apr; 44(4):329-33. PubMed ID: 20654146
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiological characteristics and related influencing factors on Japanese encephalitis in Hainan Province].
Pan XH; Sun LY; Wang CL; Zhu J; Fu ZW; Zeng ZC; Zeng XX; Yan XJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 May; 30(5):471-4. PubMed ID: 19799143
[TBL] [Abstract][Full Text] [Related]
6. [Analysis on surveillance data regarding the level of Japanese encephalitis antibody in Heilongjiang. province, 2006].
An ZJ; Ma YJ; Bo F; Huang H; Zhang ST
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Dec; 28(12):1186-9. PubMed ID: 18476578
[TBL] [Abstract][Full Text] [Related]
7. [Analysis on data from the clinical acute viral encephalitis surveillance system in three prefectures in Shaanxi during 2005 - 2006].
Zhang SB; Yin ZD; Suraratdecha C; Hills SL; Liu XZ; Li YX; Xia XQ; Liang GD; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):895-8. PubMed ID: 19173854
[TBL] [Abstract][Full Text] [Related]
8. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of rubella in female migrant factory workers in Shenzhen, China.
Mou J; Griffiths SM; Fong HF; Hu Q; Xie X; He Y; Ma H; Cheng J
Vaccine; 2010 Nov; 28(50):7844-51. PubMed ID: 20937319
[TBL] [Abstract][Full Text] [Related]
10. [Surveillance and control of Japanese encephalitis in Henan province, 1950 - 2008].
Tang XY; Xu BL; Guo WS; Li XL
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):923-6. PubMed ID: 20193229
[TBL] [Abstract][Full Text] [Related]
11. [Surveillance on Japanese encephalitis in Henan province, 2006 - 2010].
Tang XY; Kang K; Li XL; Chen HM; Xu BL
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Nov; 32(11):1128-30. PubMed ID: 22336549
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships.
Tseng HF; Tan HF; Chang CK; Huang WL; Ho WC
Am J Infect Control; 2003 Nov; 31(7):435-40. PubMed ID: 14639442
[TBL] [Abstract][Full Text] [Related]
13. Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004.
Arai S; Matsunaga Y; Takasaki T; Tanaka-Taya K; Taniguchi K; Okabe N; Kurane I;
Jpn J Infect Dis; 2008 Sep; 61(5):333-8. PubMed ID: 18806337
[TBL] [Abstract][Full Text] [Related]
14. A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic.
Gajanana A; Thenmozhi V; Samuel PP; Reuben R
Bull World Health Organ; 1995; 73(2):237-44. PubMed ID: 7743596
[TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
Puthanakit T; Aurpibul L; Yoksan S; Sirisanthana T; Sirisanthana V
Vaccine; 2007 Nov; 25(49):8257-61. PubMed ID: 17964009
[TBL] [Abstract][Full Text] [Related]
16. Contextual risk factors for regional distribution of Japanese encephalitis in the People's Republic of China.
Cao M; Feng Z; Zhang J; Ma J; Li X
Trop Med Int Health; 2010 Aug; 15(8):918-23. PubMed ID: 20561307
[TBL] [Abstract][Full Text] [Related]
17. Serological and molecular diagnosis of Japanese encephalitis reveals an increasing public health problem in the state of West Bengal, India.
Sarkar A; Taraphdar D; Mukhopadhyay SK; Chakrabarti S; Chatterjee S
Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):15-9. PubMed ID: 21993242
[TBL] [Abstract][Full Text] [Related]
18. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
19. Natural Japanese encephalitis virus infection among humans in west and east Japan shows the need to continue a vaccination program.
Konishi E; Kitai Y; Tabei Y; Nishimura K; Harada S
Vaccine; 2010 Mar; 28(14):2664-70. PubMed ID: 20080072
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
Yang SE; Pan MJ; Tseng HF; Liau MY
Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
